Austin Health

Title
Single oral dose pharmacokinetics of tiapride in patients with Huntington's disease.
Publication Date
1987-05-16
Author(s)
Norman, Trevor R
Chiu, E
James, R H
Gregory, M S
Type of document
Journal Article
Abstract
The pharmacokinetic properties of a single oral dose of 100 mg of tiapride were studied in six patients with Huntington's disease. The results for five patients were consistent with a two compartment open model. Peak plasma concentrations were observed within 2 h following drug administration with a mean value of 0.92 micrograms/ml being recorded. The drug was rapidly eliminated as unmetabolised tiapride in the urine, 51% of the dose was recovered in 24 h. The plasma elimination half-life was 5.3 h and the average apparent plasma clearance was 16.6 l/h.
Link
Citation
European Journal of Clinical Pharmacology; 32(6): 583-6
Jornal Title
European journal of clinical pharmacology

Files:

NameSizeformatDescriptionLink